http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009520034-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
filingDate 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009520034-A
titleOfInvention Use of benzo-fused heterocyclic sulfamide derivatives to treat depression
abstract The present invention is a method of treating depression, which comprises one or more novel benzoates of formula (I) and formula (II) as defined herein for a subject in need thereof. Administering a fused heterocyclic sulfamide derivative in a therapeutically effective amount. The present invention is directed to a method of treating depression that includes monotherapy and alternatively co-treatment with at least one antidepressant.
priorityDate 2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004505043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002515875-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427853863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67557716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416203774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419968960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433676664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414899547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419968939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2821746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154553610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11594261

Total number of triples: 38.